Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

XTL Biopharmaceuticals Ltd. (XTLB)

  • Technical Exchange News
  • April 02, 2024, 19:13 UTC
  • 38
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Outlook Therapeutics Inc. (OTLK)

  • Technical Exchange News
  • April 02, 2024, 19:12 UTC
  • 39
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

XTL Biopharmaceuticals Ltd. (XTLB)

  • Technical Exchange News
  • April 02, 2024, 19:12 UTC
  • 39
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Outlook Therapeutics Inc. (OTLK)

  • Technical Exchange News
  • April 02, 2024, 19:11 UTC
  • 39
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Sensei Biotherapeutics Inc (SNSE)

  • Technical Exchange News
  • April 01, 2024, 21:51 UTC
  • 39
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Ocugen Inc. (OCGN)

  • Technical Exchange News
  • April 01, 2024, 21:51 UTC
  • 39
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

First Wave BioPharma Inc. (FWBI)

  • Technical Exchange News
  • April 01, 2024, 21:51 UTC
  • 37
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Sensei Biotherapeutics Inc (SNSE)

  • Technical Exchange News
  • April 01, 2024, 19:41 UTC
  • 39
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Ocugen Inc. (OCGN)

  • Technical Exchange News
  • April 01, 2024, 19:40 UTC
  • 39
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

First Wave BioPharma Inc. (FWBI)

  • Technical Exchange News
  • April 01, 2024, 19:40 UTC
  • 38
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 995
  • 996
  • 997
  • 998
  • 999
  • Next

Search

News categories

  • Technical Exchange News(14604)
  • Event(6229)
  • SEC News(385338)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(235128)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin